Amniotic mesenchymal stem cell therapy(Amniotics)

N/A

Report date: 2023/05/11 13:42:08

Base Information

Drug NameAmniotic mesenchymal stem cell therapy(Amniotics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Idiopathic Pulmonary FibrosisLung Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmniotics AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Idiopathic Pulmonary FibrosisLung Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A